相关实验视频
Updated: May 15, 2025

09:48
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
290
微RNA纳米配方:一种对抗瘤活性有希望的方法
Abhishesh Kumar Badal1, Arnab Nayek2, Ruby Dhar3
1Amity University Haryana, Panchgaon, Manesar, Gurugram, Haryana, India.
Investigational new drugs
|May 14, 2025
概括
RNA纳米粒子通过将微RNA (mi-RNA) 直接传递到瘤,为癌症治疗提供了一种有前途的方法. 这种有针对性的治疗增强了抗瘤疗效,并最大限度地减少了副作用,推动了癌症治疗策略的发展.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 纳米技术 纳米技术
背景情况:
- 癌症仍然是导致死亡的主要原因,化学抵抗和二次瘤带来了重大挑战.
- 当前的抗癌药物往往面临由于毒性和副作用的限制.
- 微RNAs (mi-RNAs) 是关键的基因调节者,与癌症发展有关,具有作为生物标志物和治疗药物的潜力.
研究的目的:
- 审查微RNA纳米配方的开发,以改善癌症治疗.
- 评估RNA纳米颗粒的潜力,以有针对性地传递mi-RNA和anti-mi-RNA.
- 评估这些纳米配方对各种恶性瘤的抗瘤疗效.
主要方法:
- 专注于用于药物输送的RNA纳米技术平台.
- 利用RNA纳米颗粒用于针对性地传递siRNA和anti-mi-RNA等治疗剂.
- 采用抗体和/或结合来增强纳米粒子向和持续释放.
主要成果:
- RNA纳米粒子显示出有利的生物分布和有效的瘤细胞向.
- 动物模型显示成功抑制瘤生长使用RNA纳米粒子提供治疗药物.
- 纳米粒子结合改善了向传递,持续释放,并减少了系统性损伤.
结论:
- 微RNA纳米配方显示出增强细胞吸收,生物可用性和瘤积累的潜力.
- 使用RNA纳米粒子的有针对性的输送系统可以提高抗瘤疗效.
- RNA纳米技术的进步对临床瘤学和个性化癌症治疗具有重大前景.
更多相关视频
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.3K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.6K
相关概念视频
MicroRNAs
2.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K
siRNA - Small Interfering RNAs
16.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.3K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K